...
首页> 外文期刊>Journal of Neuropathology and Experimental Neurology: Official Journal of the American Association of Neuropathologists, Inc >Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis
【24h】

Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis

机译:多发性硬化症脱髓鞘区域及其周围区域清道夫受体的选择性上调

获取原文
获取原文并翻译 | 示例
           

摘要

Autoantibodies and complement opsonization have been implicated in the process of demyelination in the major human CNS demyelinating disease multiple sclerosis (MS), but scavenger receptors (SRs) may also play pathogenetic roles. We characterized SR mRNA and protein expression in postmortem brain tissue from 13 MS patients in relation to active demyelination. CD68, chemokine (C-X-C motif) ligand 16 (CXCL16), class A macrophage SR (SR-AI/II), LOX-1 (lectin-like oxidized low-density lipoprotein receptor 1), Fc??RIII, and LRP-1 (low-density lipoprotein receptor-related protein 1) mRNA were upregulated in the rims of chronic active MS lesions. CD68 and CXCL16 mRNA were also upregulated around chronic active MS lesions. By immunohistochemistry, CD68, CXCL16, and SR-AI/II were expressed by foamy macrophages in the rim and by ramified microglia around chronic active MS lesions. CXCL16 and SR-AI/II were also expressed by astrocytes in MS lesions and by primary human microglia and astrocytes in vitro. These data suggest that SRs are involved in myelin uptake in MS, and that upregulation of CD68, CXCL16, and SR-AI/II is one of the initial events in microglia as they initiate myelin phagocytosis. As demyelination continues, additional upregulation of LOX-1, Fc??RIII, and LRP-1 may facilitate this process. ? 2013 by the American Association of Neuropathologists, Inc.
机译:在主要的人CNS脱髓鞘疾病多发性硬化症(MS)的脱髓鞘过程中已经涉及了自身抗体和补体调理作用,但清道夫受体(SR)可能也起着致病作用。我们表征了13名MS患者死后脑组织中SR mRNA和蛋白表达与主动脱髓鞘的关系。 CD68,趋化因子(CXC基序)配体16(CXCL16),A类巨噬细胞SR(SR-AI / II),LOX-1(凝集素样氧化的低密度脂蛋白受体1),FcγRIII和LRP-1 (低密度脂蛋白受体相关蛋白1)mRNA在慢性活动性MS病变的边缘上调。 CD68和CXCL16 mRNA在慢性活动性MS病变周围也被上调。通过免疫组织化学,CD68,CXCL16和SR-AI / II由边缘的泡沫巨噬细胞和慢性活动性MS病变周围的分支小胶质细胞表达。 CXCL16和SR-AI / II还在MS病变中由星形胶质细胞表达,在体外也由原代人小胶质细胞和星形胶质细胞表达。这些数据表明,SR与MS中的髓磷脂摄取有关,而CD68,CXCL16和SR-AI / II的上调是小胶质细胞的初始事件之一,因为它们引发了髓磷脂的吞噬作用。随着脱髓鞘作用的继续进行,LOX-1,FcγRIII和LRP-1的额外上调可以促进这一过程。 ?美国神经病理学家协会,2013年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号